Form 8-K - Current report:
SEC Accession No. 0001104659-25-052220
Filing Date
2025-05-23
Accepted
2025-05-23 07:12:39
Documents
13
Period of Report
2025-05-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516049d1_8k.htm   iXBRL 8-K 35263
2 EXHIBIT 99.1 tm2516049d1_ex99-1.htm EX-99.1 27483
  Complete submission text file 0001104659-25-052220.txt   239777

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vstm-20250522.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20250522_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20250522_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2516049d1_8k_htm.xml XML 3675
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 25979226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)